We herein tested this hypothesis by investigating the effect of immunomodulation with SA-4-1BBL on antigen-, TGF-β-, and tumor-mediated conversion of conventional CD4+ T cells into iTreg cells. This evidence concerns the gene TGFB1 and neoplasm.